Notably, this myeloid-leukemia suppressive role of NIK differs from its tumor-promoting role in other lymphomas and functions to repress canonical NF-κB signaling, indicating that canonical and noncanonical NF-κB signaling may have opposing roles in AML. The gene discussed is MAP3K14; the disease is lymphoma.